Abstract
Brief episodes of ischemia and reperfusion precondition the myocardium and reduce the infarct size and following sustained ischemia. This phenomenon is termed as ischemic preconditioning (PC). PC is a powerful endogenous protection and has been demonstrated in dogs, pigs, rabbits and rats and humans. This protection is characterized as a reduction of infarct size and an improvement of postischemic cardiac dysfunction.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74: 1124–36.
Yellon DM, Alkhulaifi AM, Browne EE and Pugsley WB. Ischaemic preconditioning limits infarct size in the rat heart. Cardiovasc Res 1992; 26: 983–987.
Liu GS, Thornton J, Van Winkle DM, Stanley AWH, Olsson RA and Downey JM. Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart. Circulation 1991; 84: 350–356.
Scott RJ, Rohmann S, Braun ER and Schaper W. Ischemic preconditioning reduces infarct size in swine myocardium. Circ Res 1990; 66: 1133–1142.
Noda T, Minatoguchi S, Fujii K, Hori M, Ito T, Kanmatsuse K, Matsuzaki M, Miura T, Nonogi H, Tada M, Tanaka M, Fujiwara H. Evidence for the delayed effect in human ischemic preconditioning. J Am Coll Cardiol 1999; 34: 1966–74.
Eisen A, Fisman EZ, Rubenfire M, Freimark D, McKechnie R, Tenenbaum A, Motro M, Adler Y. Ischemic preconditioning: nearly two decades of research. A comprehensive review. Atherosclerosis 2004; 172: 201–210.
Ottani F, Galvani M, Ferrini D, Sorbello F, Limonetti P, Pantoli D, Rusticali F. Prodromal angina limit infarct size. A role for ischemic preconditioning. Circulation 1995; 91: 291–7.
Nakagawa Y, Ito H, Kitakaze M, Kusuoka H, Hori M, Kuzuya T, Higashino Y, Fujii K, Minamino T. Effect of angina pectoris on myocardial protection in patients with reperfused anterior wall myocardial infarction: retrospective clinical evidence of “preconditioning”.” J Am Coll Cardiol 1995; 25: 1076–83.
Thornton JD, Liu GS, Olsson RA, Downey JM. Intravenous pretreatment with A1-selective adenosine analogues protects the heart against infarction. Circulation 1992; 85: 659–65.
Mahiko G, Liu Y, Yang XM, Ardell JL, Cohen MV, Downey JM. Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ Res 1995; 77: 611–621.
Wang GY, Wu S, Pei JM, Yu XC, Wong TM. Kappa- but not delta-opioid receptors mediate effects of ischemic preconditioning on both infarct and arrhythmia in rats. Am J Physiol Heart Circ Physiol 2001; 280: H384–91.
Bankwara Z, Hale SL, Kloner RA. α-Adrenoceptor stimulation with exogenous norepinephrine or release of endogenous catecholamines mimics ischemic preconditioning. Circulation 1994; 90: 1023–8.
Tsuchida A, Liu Y, Liu GS, Choen MV, Downey JM. α1-adrenergic agonist precondition rabbit ischemic myocardium independent of adenosine by direct activation of protein kinase C. Circ Res 1994; 75: 576–585.
Kariya T, Minatoguchi S, Ohno T, Yamashita K, Uno Y, Arai M, Koshiji M, Fujiwara T, Fujiwara H. Infarct size-reducing effect to ischemic preconditioning is related to α1b-adrenoceptors but not to α1a-adrenoceptors in rabbits. J Cardiovasc Pharmacol 1997; 30: 437–445.
Tanaka M, Fujiwara H, Yamasaki K, Sasayama S. Superoxide dismutase and N-2-mercaptopropionyl glycine attenuate infarct size limitation effect of ischaemic preconditioning in the rabbit. Cardiovasc Res 1994; 28: 980–6.
Ytrehus K, Liu Y and Downey J. Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Phys 1994; 266: H1145-H1152.
Gross GJ, Auchampach J. Blockade of ATP-sensitive potassium channels prevent myocardial preconditioning in dogs. Circ Res 1992; 70: 223–33.
Hide EJ, Thiemermann C. Limitation of myocardial infarct size in the rabbit by ischaemic preconditioning is abolished by sodium 5-hydroxydecanoate. Cardiovasc Res 1996; 31: 941–946.
The IONA Study Group. Effect of nicorandil on coronary events in patients with stable angina: the impact of Nicorandil in Angina (IONA) randomized trial. Lancet 2002; 359: 1269–1275.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Minatoguchi, S. (2019). Ischemic Preconditioning. In: Cardioprotection Against Acute Myocardial Infarction. Springer, Singapore. https://doi.org/10.1007/978-981-15-0167-8_2
Download citation
DOI: https://doi.org/10.1007/978-981-15-0167-8_2
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-0165-4
Online ISBN: 978-981-15-0167-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)